8,042 Shares in Tenet Healthcare Corporation $THC Bought by Caprock Group LLC

Caprock Group LLC acquired a new position in Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 8,042 shares of the company’s stock, valued at approximately $1,633,000.

Other institutional investors have also recently made changes to their positions in the company. Norges Bank bought a new stake in Tenet Healthcare during the second quarter worth approximately $206,981,000. Boston Partners increased its position in shares of Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares during the last quarter. Alliancebernstein L.P. lifted its position in Tenet Healthcare by 375.7% in the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares during the last quarter. Holocene Advisors LP bought a new position in Tenet Healthcare during the second quarter valued at $102,855,000. Finally, WCM Investment Management LLC lifted its holdings in shares of Tenet Healthcare by 244.4% in the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently commented on THC shares. Barclays upped their price target on shares of Tenet Healthcare from $240.00 to $257.00 and gave the company an “overweight” rating in a report on Friday. Truist Financial reiterated a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of Tenet Healthcare in a report on Monday, November 3rd. TD Cowen restated a “buy” rating on shares of Tenet Healthcare in a report on Thursday. JPMorgan Chase & Co. lifted their target price on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Royal Bank Of Canada upped their price target on shares of Tenet Healthcare from $253.00 to $277.00 and gave the stock an “outperform” rating in a report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $242.82.

Insider Activity

In other news, Director Nadja West sold 2,178 shares of the business’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares of the company’s stock, valued at approximately $5,623,945.60. The trade was a 7.10% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Down 0.6%

NYSE:THC opened at $230.90 on Friday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.64. The firm has a market cap of $20.29 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 0.97 and a beta of 1.44. The company has a 50-day moving average of $198.82 and a 200 day moving average of $194.69. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $235.77.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. The firm had revenue of $5.53 billion during the quarter, compared to analysts’ expectations of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The company’s revenue was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, research analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.